Invivyd (IVVD) Common Equity (2020 - 2025)
Invivyd (IVVD) posted Common Equity of $241.5 million for Q4 2025, up 159.53% on a QoQ basis from $93.1 million in Q3 2025, and up 257.63% year-over-year from $67.5 million in Q4 2024.
Invivyd (IVVD) Common Equity (2020 - 2025) Analysis & Trends
Invivyd's Common Equity history runs 6 years deep, the most recent figure standing at $241.5 million for Q4 2025.
- Quarterly Common Equity rose 257.63% year-over-year to $241.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $241.5 million (up 257.63% YoY) and the FY2025 annual result came in at $241.5 million, up 257.63% from the prior year.
- Common Equity was $241.5 million for Q4 2025 at Invivyd, up from $93.1 million in the prior quarter.
- Across five years, Common Equity topped out at $633.2 million in Q3 2021 and bottomed at -$144.6 million in Q2 2021.
- A 5-year average of $224.2 million and a median of $210.0 million in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2021 — Common Equity surged 955.21% — and 2025, when it tumbled 69.66%.
- Invivyd's Common Equity stood at $558.0 million in 2021, then plunged by 36.21% to $356.0 million in 2022, then sank by 50.15% to $177.5 million in 2023, then slumped by 61.94% to $67.5 million in 2024, then soared by 257.63% to $241.5 million in 2025.
- Business Quant data shows IVVD's Common Equity at $241.5 million in Q4 2025, $93.1 million in Q3 2025, and $42.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -98.34 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 14.38 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4.76 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 1.50 Bn |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | 241.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 241.54 Mn |
| Sep 30, 2025 | 93.07 Mn |
| Jun 30, 2025 | 42.79 Mn |
| Mar 31, 2025 | 54.15 Mn |
| Dec 31, 2024 | 67.54 Mn |
| Sep 30, 2024 | 83.16 Mn |
| Jun 30, 2024 | 140.64 Mn |
| Mar 31, 2024 | 178.50 Mn |
| Dec 31, 2023 | 177.47 Mn |
| Sep 30, 2023 | 246.50 Mn |
| Jun 30, 2023 | 281.56 Mn |
| Mar 31, 2023 | 326.75 Mn |
| Dec 31, 2022 | 355.97 Mn |
| Sep 30, 2022 | 377.44 Mn |
| Jun 30, 2022 | 414.84 Mn |
| Mar 31, 2022 | 459.39 Mn |
| Dec 31, 2021 | 558.02 Mn |
| Sep 30, 2021 | 633.21 Mn |
| Jun 30, 2021 | -144.62 Mn |
| Mar 31, 2021 | -103.36 Mn |